13. June 2024
Best Lawyers 2025 – 19 ARQIS lawyers are among Germany's best

ARQIS‘ lawyers are once again among the best in Germany this yar. The award „The Best Lawyers in Germany 2025“, which is presented by the US publisher Best Lawyers in cooperation with Handelsblatt, is given to the best lawyers and commercial law firms in Germany. This year, a total of 19 colleagues are among the best minds in the sector. They were determinded in a peer review survey. Many were recommended for their work in several specialist areas.

„The Best Lawyers in Germany 2025” include:

In cooperation with Best Lawyers, Handelsblatt is once again presenting the "Ones to Watch in Germany" category this year. This category recognizes young talents who have generally been in practice for three to eight years and have already earned an exceptional reputation among competitors and clients.

These include:

You can find the entire list of award-winning law firms and lawyers in the Handelsblatt Best Lawyers Special.

16. May 2024
ARQIS advises MIURA on the acquisition of CERTUSS Dampfautomaten GmbH & Co. KG

ARQIS has advised MIURA Co., LTD on the acquisition of all shares in CERTUSS Dampfautomaten GmbH & Co. KG. MIURA Co., LTD is a leading Japanese manufacturer of industrial boilers.

CERTUSS sells, installs, and repairs boilers and other equipment, and has built a solid business foundation as an industry leader in Germany. CERTUSS has developed business in Germany for more than 60 years and has built a strong relationship of trust with its customers. Through this grouping, both companies aim to develop new customers in Europe, as well as to improve business efficiency and provide higher quality products and services.

In this transaction, ARQIS acted for MIURA for the first time and on the basis of a referral by a long-standing Japanese client. ARQIS led an international team of legal counsel, including counsel in the USA and the UK.


Advisors to MIURA

ARQIS (Dusseldorf/Munich): Eberhard Hafermalz (Lead), Dr. Shigeo Yamaguchi (both Japan Desk/M&A), Dr. Friedrich Gebert (Regulatory), Dr. Ulrich Lienhard (Real Estate), Lisa-Marie Niklas (HR.Law), Marcus Nothhelfer (IP); Counsel: Donata Lasson (HR.Law), Dennis Reisich (Tax), Anja Mehrtens (HR.Law), Dr. Yohei Nagata-Vogelsang (Japan Desk/M&A); Managing Associates: Diana Puchowezki (Real Estate), Rolf Tichy (IP); Associates: Kiyomi Zimmer, Marius Mesenbrink (both Japan Desk/M&A), Dr. Bernhard Gröhe (Regulatory), Dr. Hendrik Völkerding, Anna Munsch (both HR.Law), Thomas Lipsky (IP).

10. May 2024
ARQIS advises Fast Fitness Japan on the acquisition of Eighty 8 Health & Fitness

ARQIS has advised Fast Fitness Japan, Inc. on the acquisition of a controlling share stake in Eighty 8 Health & Fitness B.V., which entity heads a group that holds the Master Franchisee Rights for Anytime Fitness in Germany.

Fast Fitness Japan, Inc. is listed on the prime market of the Tokyo Stock Exchange and directly operates and franchises Anytime Fitness 24-hour 365-day fitness clubs as the Master Franchisee in Japan. It currently operates 1,100 clubs in Japan. Through this acquisition, Fast Fitness Japan may now expand its Anytime Fitness business to operations in Germany.

ARQIS (Lead Germany) collaborated with an international legal team consisting of law firms in The Netherlands and the USA.


Advisors to Fast Fitness Japan

ARQIS (Dusseldorf): Eberhard Hafermalz (Lead, Japan Desk/M&A), Marius Mesenbrink (Japan Desk/M&A), Partner: Dr. Friedrich Gebert (Regulatory), Johannes Landry (Restructuring), Dr. Ulrich Lienhard (Real Estate), Counsel: Anja Mehrtens (HR.Law); Associates: Dr. Bernhard Gröhe (Regulatory), Anna Munsch (HR.Law), Diana Puchowezki (Real Estate)

10. April 2024
ARQIS advises CONSTELLATION CAPITAL on the acquisition of HPN Industrie-
verpackungen GmbH and Peter Gomber GmbH

ARQIS has advised the Swiss investor group CONSTELLATION CAPITAL on the acquisition of HPN Industrieverpackungen GmbH and Peter Gomber GmbH. Both companies are now part of the ARCA Group, which belongs to CONSTELLATION.

HPN Industrieverpackungen GmbH from Baden-Wuerttemberg specializes in the production of wooden pallets, boxes and packaging services. Thanks to long-standing customer relationships and a high degree of digitalization, HPN can offer efficient and high-quality packaging solutions that meet individual customer needs.

Peter Gomber GmbH is a wooden packaging specialist in Rhineland-Palatinate that has been operated as a traditional family business since it was founded in 1946. Peter Gomber GmbH specializes in the manufacture of wooden pallets, boxes and packaging solutions and has achieved his success over the years through tailor-made solutions and close customer relationships, resulting in an excellent reputation in the region. Peter Gomber GmbH will keep its independent market presence. Franz Schuler, who has successfully managed the company for more than 20 years, will remain at the helm. Together with the support of ARCA, this ensures a succession solution for Peter Gomber GmbH and continuity for customers and partners.

The acquisition of HPN forms the basis of the ARCA Group's growth strategy and geographical expansion. Future acquisitions are intended to create a close-knit network of wood packaging and packaging service companies that will benefit from synergies in purchasing, the professionalization of processes and digital transformation. With its proprietary ERP system, HPN will play a key role within the ARCA Group, particularly in terms of digitalization. HPN will continue to operate independently on the market with the same management team, which will continue to support the further growth strategy of HPN and ARCA in the future. The managing director and former owner, Martin Fix, supports the strategic vision of ARCA and has reinvested significantly in the ARCA Group.

The ARCA Group is to be expanded through further acquisitions as part of a buy & build strategy to become the market leader in the field of wooden packaging and packaging services in German-speaking countries. The focus is on implementing a consolidation strategy in order to create a group of companies that offers customized packaging solutions and packaging services.

CONSTELLATION CAPITAL is a Swiss investment group founded in 1992 and based in Freienbach on Lake Zurich. It pursues a buy & build strategy that focuses on majority investments in medium-sized companies in the business service, education & lifestyle and healthcare sectors in Switzerland, Germany and Austria.

The ARQIS team led by Dr. Lars Laeger has already advised CONSTELLATION on transactions in the past and is now assisting CONSTELLATION for the first time with the acquisition of a platform as part of a buy & build strategy.



ARQIS (Dusseldorf/Munich): Dr. Lars Laeger (M&A, Lead), Thomas Chwalek (M&A), Johannes Landry (Financing), Dr. Ulrich Lienhard (Real Estate Law), Tobias Neufeld (Data Protection), Marcus Nothhelfer (IP/Commercial), Lisa-Marie Niklas (Employment Law); Counsel: Jens Knipping (Tax), Dr. Nima Hanifi-Atashgah (M&A), Anja Mehrtens, Donata Lasson (both Employment Law), Sina Janke (Compliance); Associates: Dr. Denis Schütz, Katrin Ludwig (both M&A), Tim Bresemann, Diana Puchowezki (both Real Estate Law), Carolin Schlütter-Lückel (Financing), Martin Weingärtner, Dr. Hendrik Völkerding, Sabine Müller, Anna Hellmann, Anna Munsch, Dr. Dennis Ratschkowski (all Employment Law), Daniel Schlemann, Marius Mesenbrink (both Data Protection), Thomas Lipsky, Rolf Tichy, Nora Stratmann (all IP/Commercial); Trademarks: Carolin von Fritsch; Legal Specialist: Qing Xia (M&A)

8. April 2024
ARQIS advises SachsenEnergie AG on the acquisition of a solar farm in Poland

ARQIS has advised SachsenEnergie AG on the acquisition of a solar farm in Poland from German solar developers and installers Goldbeck Solar GmbH and SUNCATCHER Group.

SachsenEnergie AG acquired a 9-MWp solar power complex, being a cluster of two ground-mounted solar farms located in the western Polish town of Barlinek. Equipped with over 16,500 solar panels, the Barlinek plants are expected to be able to produce some 8,982 GWh of electricity per year, or enough to power around 4,000 households. Shortly after closing the productive site was commissioned in early 2024. The site is planned to be extended to 11.1 MW by the end of 2024.

SachsenEnergie AG is the largest municipal supplier in eastern Germany. The company would like to grow its renewable business via self-developed PV- and Wind-projects as well as further acquisitions in Germany and Europe. With PV Barlinek, SachsenEnergie AG acquired for the first time a ground-mounted PV system in Poland and thereby increased their geographical footprint.

ARQIS acted for SachsenEnergie AG for the first time. The lead partner Dr. Lars Laeger was recommended by the market. The client is significant for the law firm as it impressively underlines the special focus on M&A in regulated industries, in particular renewables. ARQIS was supported in Poland by Wolf Theiss in local law.


Advisors to SachsenEnergie AG

ARQIS (Dusseldorf): Dr. Lars Laeger (Lead; M&A), Partner: Dr. Friedrich Gebert (Public and Regulatory), Counsel: Jens Knipping (Tax), Managing Associates: Kamil Flak, Dr. Denis Schütz (both M&A), Associates: Dr. Bernhard Gröhe, Luise Schüling (both Public and Regulatory)

Wolf Theiss (Warsaw): Igor Muszynski, Pawel Szumowski and Marika Grzybowska

19. March 2024
ARQIS advises Nifco on the sale of Nifco Germany to AEQUITA

ARQIS has advised the Japanese Nifco Inc. on the sale of its subsidiary, Nifco Germany GmbH, to AEQUITA SE & Co. KGaA, a global industrial group headquartered in Munich. Nifco Germany develops and produces injection-molded plastic components for the automotive industry. The company generates revenues of more than EUR 200 million with over 1,100 employees across its locations in Germany, the USA, and Serbia.

Nifco Inc. is a leading manufacturer of plastic components and fasteners for the automotive and life-solution industries. With its headquarters in Japan, Nifco operates globally, providing a wide range of products contributing to the functionality and comfort of high-quality vehicles, household or fashion products. Nifco's commitment to innovation, quality, and environmental sustainability has made it a preferred partner for industry-leading companies worldwide.

The transaction is expected to be completed in the first half of 2024, subject to approval by the relevant authorities.


Advisors to Nifco Group

ARQIS (Dusseldorf/Munich): Dr. Shigeo Yamaguchi, Eberhard Hafermalz (both Lead; Japandesk/M&A), Partner: Dr. Mauritz von Einem (PE/Tax), Dr. Meiko Dillmann (Japandesk/M&A), Johannes Landry (Restructuring), Marcus Nothhelfer (IP/Commercial), Lisa-Marie Niklas (HR.Law), Counsel: Dennis Reisich (PE/Tax), Associates: Kiyomi Zimmer (Japandesk/M&A), Marius Mesenbrink (Japandesk/M&A), Thomas Lipsky (IP/Commercial), Anna Munsch (HR.Law), Daniel Schlemann (Data.Law)

6. March 2024
ARQIS advises Karo Healthcare on the acquisition of Proctosedyl® from Bayer

ARQIS has advised Karo Healthcare on the acquisition of Proctosedyl® from Bayer. The transaction transfers the dossier ownership and an exclusive license to the trademark to Bayer’s OTC brand Proctosedyl® in Italy to Karo.

This acquisition amplifies Karo’s presence in Italy while aligning with Karo’s M&A strategy of focusing on brands with strong equity in categories associated with discomfort and embarrassment. Proctosedyl® is a leading brand in Italy for the treatment of hemorrhoids. The acquisition strengthens and scales Karo’s position in one of its core categories, Digestive Health, which includes global brands such Proct® and Hemoproct®.

“This acquisition adds a trusted brand that addresses an often-neglected category with untapped potential. We are excited about the opportunity to enhance access to reliable treatments for Italian consumers and to add further scale and reach to our Italian business”, says Matt Roberts, CCO.

The acquisition has been executed as an asset deal, excluding personnel and manufacturing sites, which mitigates commercial risk and ensures the delivery of a seamless integration. Karo will leverage its existing infrastructure and make use of established partners in Italy.

The transaction was the first time the ARQIS team around Jörn-Christian Schulze acted for Karo Healthcare, a Swedish EQT investment company. The decisive factors for the instruction were the team's focus in healthcare/life science as well as private equity.


Advisors to Karo Healthcare

ARQIS (Dusseldorf/Munich): Dr. Jörn-Christian Schulze (Lead), Dr. Maximilian Backhaus, Malte Griepenburg (all Transactions), Partners: Dr. Friedrich Gebert (Regulatory), Marcus Nothhelfer (IP), Managing Associates: Daniel Schlemann (Data Law), Rolf Tichy (IP), Associate: Dr. Bernhard Gröhe (Regulatory), Trademark Professional: Carolin von Fritsch

Franzosi – Dal Negro – Setti (Milan): Stefano Giberti, Francesco Setti (both Italian regulatory law)

19. February 2024
ARQIS advises Omnes Capital on a majority stake in EEF Erneuerbare Energien Fabrik

ARQIS has advised Omnes on a majority shareholding in EEF Erneuerbare Energien Fabrik GmbH.

With the financial support of Omnes, EEF will drive forward the energy transition 2.0 and the decarbonization of the energy market as an expert in the development, implementation and long-term operation of renewable energy projects. With three locations in Berlin, Hamburg and Wiesbaden and an experienced team along the entire value chain, EEF is excellently positioned to develop projects with the necessary technical expertise close to the location and to reshape the landscape of the energy market. Under the leadership of the three co-partners and managing directors Roman Bredlow, Niklas Hinz and Nigel Nyirenda, EEF is paving the way to a sustainable future with innovative energy solutions.

Omnes is a major player in the renewable energy and infrastructure sectors with approximately €6 billion in assets under management. As an entrepreneur-led investor, Omnes, through its funds, provides its partners with the equity they need to grow and meet the challenges of the energy transition. The investment in EEF was realized through Capenergie 5, which is Omnes' fifth fund focused on renewable energy. The team led by ARQIS partner Dr. Mirjam Boche regularly advises Omnes Capital, including on the investment in the Austrian-German photovoltaic specialist CCE and the investment in the pan-European PV developer Ilos Projects.

The three co-shareholders of EEF Erneuerbare Energien Fabrik were advised by Dr. Michael Burg, co-founder and partner of the law firm Lighthouse Legal.


Advisors to Omnes Capital

ARQIS (Dusseldorf): Dr. Mirjam Boche (lead partner, M&A), Conrad Wiza (M&A), Dr. Nima Hanifi-Atashgah (M&A), Martin Weingärtner (employment law), Rolf Tichy (IP)

16. February 2024
The Legal 500 Germany Awards 2024: ARQIS wins the coveted "ESG Firm of the Year" award

ARQIS wins the first The Legal 500 Germany Awards 2024 and is honoured as “ESG Firm of the Year.” ARQIS travelled to Frankfurt for the awards ceremony on 16 February 2024 with a total of three nominations: In addition to the “ESG Firm of the Year” category, the law firm was shortlisted in the “Labour & Employment Team of the Year” category. Counsel Anja Mehrtens was also nominated as “Labour & Employment Rising Star of the Year.”

The “ESG Firm of the Year” award was received on stage by the team led by Dr Friedrich Gebert, Head of the Regulatory focus group.

“This award is for the whole team and confirms our commitment and the direction we have taken in supporting our clients with the EU Green Deal and the resulting transformation in a forward-looking manner,” says Friedrich Gebert, overwhelmed by the award.

Dr Friedrich Gebert and his team have already been praised in the Legal 500 Germany Ranking 2024, which was published beforehand. It states: “The ARQIS team is a diverse and professional team that has understood how to centre its clients and put their needs at the focus. Their ability to quickly empathise with proceedings and ensure a sustainable flow of information within the process and team is outstanding.”

In addition to the two focus group leaders Dr. Friedrich Gebert (Regulatory) and Dr. Mirjam Boche (Risk), ARQIS was present with a total of eleven people: Dr. Astrid Seehafer, Hannah Düwel, Dr. Bernhard Gröhe, Clara Schmidt, Luise Schüling (all Regulatory), Donata Lasson, Anja Mehrtens, Martin Weingärtner (all HR.Law) and Daniel Schlemann celebrated their success until dawn. Dr. Andrea-Panzer Heemeier, Managing Partner at ARQIS, explains: “ARQIS has identified ESG as a cross-focus group consulting field and put together a great team. At the same time, we have initiated some important things internally, for example ARQIS is CO222-neutral and we have dedicated our Innovation Day to the topic of ESG. We are delighted that we have now been recognised as a law firm in this forward-looking field and this spurs us on further.”

ARQIS recognised early on that it is not enough to only think in one direction when it comes to ESG issues. For this reason, the law firm also works across focus groups and forms the necessary interfaces within relevant areas of law, particularly in the field of transactions. This resulted in the approach of ESG +.
Business as usual becomes a positive contribution - fair and sustainable action for people and the environment, for present and future generations: Simply, Make business positive.
In the area of Environmental, ARQIS focuses on the decarbonisation of the economy and the regulation resulting from the EU Green Deal. In the area of Social, ESG + focuses on the social aspects of the world of work, while the area of Governance is currently characterised by national and European supply chain legislation.

The Legal 500 Germany Awards are an annual competition that has been taking place since this year, focussing on the work of lawyers, law firms and in-house teams. The awards are presented in 70 different categories and recognise special team achievements as well as those of individuals.

14. February 2024
ARQIS enters the Legal 500 ranking of leading law firms in Germany with another practice area

ARQIS has once again been listed as a recommended law firm in the recently published guide by The Legal 500 Germany in the specialist areas of labour law, corporate law, M&A and private equity (transactions: medium-sized deals) as well as insurance law (dispute resolution). For the first time, the law firm was also included in the ranking for public law (environmental and planning law). ARQIS was listed as a "Firm to watch" in the area of insurance law (advice to insurance companies). ARQIS thus joins two other areas in the Legal 500 ranking of leading law firms in Germany.



In the Legal 500 Germany rankings, ARQIS achieved Tier 4 out of 7 in the employment law category, highlighting its support for transformation and restructuring projects, including outsourcing and staff reduction measures, a key area of expertise that is covered by practice group head Dr. Andrea Panzer-Heemeier among others, while she also focuses on works council remuneration. The client evaluation states: “This advisory focus is supplemented by expertise in employment law matters relating to IT, data protection and compliance; Lisa-Marie Niklas and Tobias Neufeld who is also experienced in company pension schemes, are among the key contacts in this area.”

The core team also includes counsel Anja Mehrtens, who often uses her expertise in company pension schemes and compliance with employment law regulations in the context of transactions. The team is said to provide “very competent and, above all, binding advice in all matters of employment law.” It continues: “This is paired with great personal commitment and a very good knowledge of the specific requirements of our industry”



In the area of corporate law, the law firm once again maintains tier 4 out of 5 and in M&A (medium-sized deals €100; - €500M) ARQIS is also once again listed in tier 5 out of 6. The team, consisting of Dr. Jörn-Christian Schulze, Dr. Shigeo Yamaguchi, Dr. Mirjam Boche, Dr. Mauritz von Einem and Dr. Christof Alexander Schneider, is said to work “always very solution-oriented and close to the client”. “Our special requirements and wishes are always taken into account. The implementation always takes the form of practicable ideas.”

Tier 5/5 was achieved in the area of private equity (transactions: medium-sized deals).



ARQIS is ranked in Tier 5 out of 5 in the area of insurance law (litigation). This area is led by Dr. Mirjam Boche. Dimitrios Christopoulos is named as the central contact for in-court and out-of-court disputes that the law firm handles for insurers and policyholders.

ARQIS is listed as a “Firm to watch” for the first time in the insurance advice category (insurance law), which is a special tribute to the work of the team led by Dr. Mirjam Boche in recent years.



The category of environmental and planning law (regulatory law) deserves special mention: ARQIS is ranked here for the first time with 5 out of 5. While ARQIS was listed as a “firm to watch” in the environmental and planning law category last year, the regulatory law focus group with Dr. Friedrich Gebert and Dr. Astrid Seehafer achieved a Tier 5 out of 5 ranking this year. The practice group, which was founded in 2021, is particularly highlighted in connection with advice on ESG issues and the energy transition. “These two areas are covered by practice group head Friedrich Gebert, who is also increasingly advising on planning law mandates. Astrid Seehafer joined the team in August 2022 from Freshfields Bruckhaus Deringer and advises on product compliance.”


The Legal 500 Germany analyzes law firms and lawyers in interviews with lawyers and clients in a total of 23 practice areas and 90 rankings every year.

25. January 2024
ARQIS advises the shareholders of PRI Pneumologisches Forschungsinstitut and KLB Gesundheitsforschung Lübeck

ARQIS has advised the previous shareholders of Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH (PRI) and KLB Gesundheitsforschung Lübeck GmbH (KLB) on the sale of their shares in the institutes to Velocity Clinical Research.

Since its foundation 25 years ago, the PRI has conducted over 300 studies and is one of Europe's leading institutes in clinical research on bronchial asthma, COPD, bronchiectasis and pulmonary fibrosis. Dr. Anne-Marie Kirsten and Dr. Henrik Watz both continue to work at Velocity as Principal Investigator and Head of Clinical Trials respectively.

The KLB is located in the heart of the city of Lübeck and has been conducting clinical trials on respiratory diseases since 2008. It is dedicated to researching new active principles and diagnostic procedures in the treatment of chronic obstructive airway diseases such as bronchial asthma or smoker's lung/COPD. Dr. Andrea Ludwig-Sengpiel will also continue to work for Velocity in a leading role at the institute.

Velocity is the leading integrated network of clinical trial sites. With nearly 100 clinical trial sites and more than 220 researchers, Velocity works with pharmaceutical and biotechnology companies to discover new drugs, medical devices, diagnostics and combination products that could improve people's health and well-being. Velocity offers unified solutions for research sites to efficiently find the right patients, investigators and research collaborators for clinical trials in the U.S. and Europe.

Both the PRI and the KLB are independent entities. They have been sold together.

The ARQIS team, led by Dr. Jörn-Christian Schulze, won the mandate through a pitch. The pitch was managed by the financial advisor WMCF Advisory. The WMCF team consisted of Ulf Boenicke (Managing Partner), Pascal Florczak (Director), Alexej Koslov (Senior Associate) and Nicolas Emig (Analyst). Both firms are deeply rooted in the healthcare sector and have worked together on numerous other transactions, most recently on the sale of m.doc GmbH to CompuGroup Medical AG.


Advisors to PRI and KLB

ARQIS (Dusseldorf): Dr. Jörn-Christian Schulze (Lead), Dr. Maximilian Backhaus, Laura Ally Rizzi (all Transactions); Counsel: Jens Knipping (Tax), Anja Mehrtens (Employment); Associates: Jasmin Grünen (Transactions), Anna Munsch (Employment); Legal Specialists: Qing Xia (Transactions)

19. December 2023
ARQIS advises Fit Reisen on the sale of KMW Reisen to HomeToGo

ARQIS has advised Fit Reisen on the sale of KMW Reisen GmbH to HomeToGo. KMW Reisen GmbH (KMW) operates a leading online travel portal for short trips in the DACH region at Founded in 2001, the online pioneer Kurz Mal Weg has been part of the Fit Reisen Group ( based in Frankfurt am Main since 2016.

HomeToGo was founded in 2014 and makes holiday accommodation easily accessible to everyone. Since then, the listed Berlin-based company has grown steadily and has developed into the SaaS-enabled marketplace with the world's largest selection of holiday accommodation (over 15 million offers). HomeToGo SE is listed on the Frankfurt Stock Exchange under the ticker symbol “HTG”.

Simultaneously with the acquisition of KMW Reisen GmbH from Fit Reisen, HomeToGo acquires a majority stake in Super Urlaub GmbH. As a result of this transaction, HomeToGo will hold a 51 per cent majority stake in the combined company. This includes the two brands Kurz Mal Weg and Kurzurlaub, two leading specialists for themed holidays and hotel offers for short trips in the DACH region and neighbouring countries.

The sale of the two companies took place as part of a bidding process led by Carlsquare as M&A advisor. The parties have agreed not to disclose the purchase prices.

The leading ARQIS partner of this mandate, Dr Lars Laeger, already advised Fit Reisen on the acquisition of the business of KMW Reisen GmbH from the insolvency of the former Unister Group.


Advisors for Fit Reisen

ARQIS (Dusseldorf): Dr. Lars Laeger (Federführung; M&A), Thomas Chwalek (M&A), Johannes Landry (M&A), Lisa-Marie Niklas (Arbeitsrecht), Marcus Nothhelfer (IP); Counsel: Jens Knipping, Dennis Reisich (beide: Steuern); Managing Associates: Dr. Denis Schütz (M&A); Associates: Katrin Ludwig (M&A), Rolf Tichy (IP)